Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 14, 2025 09:25 ET | Source: 22nd Century Group, Inc.

Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers

VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA’s War on Smoking MOCKSVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- 22nd...
January 13, 2025 07:30 ET | Source: 22nd Century Group, Inc.

22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes

FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the...
January 07, 2025 08:30 ET | Source: 22nd Century Group, Inc.

22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly

Agreement covers 11 existing brands, supports launch 8 additional premium brands with Smoker Friendly retail and dealer locations Creates foundation to launch additional reduced nicotine content...
April 28, 2020 06:50 ET | Source: 22nd Century Group, Inc.

22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020

Williamsville, NY, April 28, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
April 17, 2020 12:15 ET | Source: 22nd Century Group, Inc.

FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application

WILLIAMSVILLE, NY, April 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
April 08, 2020 16:15 ET | Source: 22nd Century Group, Inc.

22nd Century Group to Hold Virtual Annual Meeting of Stockholders

Williamsville, NY, April 08, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
March 11, 2020 16:15 ET | Source: 22nd Century Group, Inc.

22nd Century Announces Important New Achievements with KeyGene

Delivers Complete High-Quality Hemp/Cannabis Genome Sequence; Establishes New Proprietary Hemp/Cannabis Bioinformatics Platform WILLIAMSVILLE, N.Y. , March 11, 2020 (GLOBE NEWSWIRE) -- 22nd Century...
March 10, 2020 16:15 ET | Source: 22nd Century Group, Inc.

22nd Century Group Adds to Leadership Team

WILLIAMSVILLE, N.Y., March 10, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
March 04, 2020 13:03 ET | Source: 22nd Century Group, Inc.

CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking

Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
March 04, 2020 06:50 ET | Source: 22nd Century Group, Inc.

Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use

Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right